A Quiet Quarter, a Thinning Pipeline:
What Q2 Licensing Data Actually Shows
At first glance, the second quarter of 2026 looked like another rough one for U.S. cannabis operators. Active business licenses fell by 1,322. The reality is considerably quieter.
According to CRB Monitor’s Q2 2026 Cannabis Business Licensing Review, roughly 1,039 of those licenses came off the books when New Mexico shifted from business-level to premise-level reporting. New Mexico did lose operators — about 300 of them — but the rest of the drop was an accounting change, not a market event. Adjusted, the national decline was closer to 0.8%, leaving active licenses at 34,226.
The more telling movement is upstream. Approved and pending licenses have fallen 28% over two years to 4,063, and pre-license applications 24% to 5,154. Both statuses have now declined for eight consecutive quarters. These are the categories that feed the active license base.
The pipeline that remains is also highly concentrated. New York alone holds 4,465 of the 5,154 pending applications nationwide, leaving just 689 spread across twelve other states.
There is genuine good news. The cultivator-to-retailer ratio fell to 1.27:1, the lowest on record and down from 2.2:1 in late 2022. The oversupply that has driven years of price compression is finally correcting, even if the market remains substantially oversupplied. Canadian licensing held steady at a two-year high.
The picture for U.S. operators is one of a market gradually resetting rather than collapsing — with very few new entrants coming in to replace those exiting.
Download the full Q2 licensing report below.
